Santen Pharmaceutical Co Ltd

Common Name
Santen Pharmaceutical
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
3,849
Ticker
4536
Exchange
TOKYO STOCK EXCHANGE
Description
Santen Pharmaceutical Co., Ltd. is a prominent pharmaceutical company focusing on ophthalmology. Established in 1890 and headquartered in Osaka, Japan, Santen specializes in the research, development,...

Santen Pharmaceutical Waste Data Preview

In 2023, Santen Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Santen Pharmaceutical's Waste Treatment Practices

In 2023, Santen Pharmaceutical generated a total of 4,838 metric tonnes of waste.

Of this amount, 43.7% of Santen Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 56.3% was disposed of through landfilling, incineration, or combustion.

Santen Pharmaceutical's Waste Recovery Rate

44%

How much of Santen Pharmaceutical's waste is recycled or recovered?

In 2023, Santen Pharmaceutical reported a total waste generation of 4,838 metric tonnes, of which 43.7% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Santen Pharmaceutical is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Has Santen Pharmaceutical reduced its environmental waste footprint over time?

Since 2019, Santen Pharmaceutical's total waste generation decreased by 16.92%, including a further 13.61% drop in 2023, highlighting a consistent and deliberate reduction in waste production over time.

Over the same period, Santen Pharmaceutical's waste recovery rate declined by 2.96%, with a further 4.97% drop in 2023, underscoring a weakening in waste diversion performance and a potential drift away from circular waste strategies.

Overall, while Santen Pharmaceutical has successfully reduced its total waste generation, its waste recovery efforts have also declined. This pattern could suggest a shift in strategy away from circular treatment methods or a lag in recovery infrastructure development.

Santen Pharmaceutical’s Waste Recovery vs. Disposal Over Time

2019202020212022202301.5 k3 k4.5 k6 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Santen Pharmaceutical’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Santen Pharmaceutical generated a total of 4,838 metric tonnes of waste.

Of this amount, 6.45% of Santen Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 93.55% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Santen Pharmaceutical’s Hazardous vs Non-Hazardous Waste Over Time

202020212022202301.5 k3 k4.5 k6 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Santen Pharmaceutical reduced the environmental impact of its waste?

Since 2019, Santen Pharmaceutical's total waste generation decreased by 16.92%, with an additional 13.61% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.

Since 2023, Santen Pharmaceutical's hazardous waste generation has decreased by 26.15%, suggesting a recent shift toward safer materials, improved waste handling protocols, or stronger compliance with environmental standards.

Overall, Santen Pharmaceutical has reduced both its total waste and hazardous waste in the last year, suggesting effective waste management practices and improved material sourcing.

How does Santen Pharmaceutical treat its hazardous waste?

In 2023, Santen Pharmaceutical reported that 312 metric tonnes of its total waste output were classified as hazardous. This represents 6.45% of its overall waste generation.

The company treated this hazardous waste using a combination of methods. Approximately 38.14% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.

Breakdown of Santen Pharmaceutical's Hazardous and Non-Hazardous Waste by Treatment Method

Non-Hazardous WasteDisposed(52.3%)Non-Hazardous WasteRecovered(41.2%)
Want Full Access to Santen Pharmaceutical's Waste Management Dataset?
Sign Up